Your browser doesn't support javascript.
loading
Efficacy and safety of high-dose Xueshuantong injection (lyophilised) in reducing the incidence of major adverse cardiovascular events in patients with unstable angina: a protocol of a randomised, parallel-arm, controlled, double-blind and multicentre clinical trial based on dual antiplatelet therapy.
Long, Wenjie; Liao, Huili; Huang, Xi; Liu, Qingqing; Tang, Yaqing; Lu, Liming; Liu, Jianhong; Yuan, Tianhui; Ling, Yan; Hong, Yu; Duan, Jiao; Lin, Weiji; Xian, Shaoxiang; Yang, Zhongqi.
Afiliação
  • Long W; Department of Geriatrics, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China.
  • Liao H; Lingnan Medical Research Center, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China.
  • Huang X; Department of Geriatrics, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China.
  • Liu Q; The First Clinical College, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China.
  • Tang Y; The First Clinical College, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China.
  • Lu L; National Drug Clinical Trial Agency Office, Guangzhou University of Traditional Chinese Medicine First Affiliated Hospital, Guangzhou, Guangdong, China.
  • Liu J; Clinical Research and Data Center, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China.
  • Yuan T; Department of Geriatrics, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China.
  • Ling Y; National Drug Clinical Trial Agency Office, Guangzhou University of Traditional Chinese Medicine First Affiliated Hospital, Guangzhou, Guangdong, China.
  • Hong Y; Department of Geriatrics, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China.
  • Duan J; Department of Geriatrics, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China.
  • Lin W; Department of Geriatrics, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China.
  • Xian S; Department of Geriatrics, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China.
  • Yang Z; Department of Geriatrics, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China.
BMJ Open ; 10(8): e038074, 2020 08 26.
Article em En | MEDLINE | ID: mdl-32847917

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Inibidores da Agregação Plaquetária / Angina Instável Tipo de estudo: Clinical_trials / Guideline / Incidence_studies / Prognostic_studies / Qualitative_research / Risk_factors_studies Limite: Humans País como assunto: Asia Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Inibidores da Agregação Plaquetária / Angina Instável Tipo de estudo: Clinical_trials / Guideline / Incidence_studies / Prognostic_studies / Qualitative_research / Risk_factors_studies Limite: Humans País como assunto: Asia Idioma: En Ano de publicação: 2020 Tipo de documento: Article